Lupus Erythematosus News and Research

RSS

Research reveals the microbial landscape of patients with systemic lupus erythematosus

Systemic lupus erythematosis (SLE) is an autoimmune disease in which the immune system targets tissues of the body, causing widespread inflammation and affecting multiple organs such as the kidney and the brain.

27 Oct 2021

Frequency domain optical imaging could reliably identify lupus arthritis and track disease progression

Systemic lupus erythematosus (SLE), commonly referred to as simply "lupus", is an autoimmune disorder where the body's immune system attacks healthy tissue.

26 Oct 2021

New research focuses on better understanding of lupus in Black women

Nine out of 10 patients with systemic lupus erythematosus - the autoimmune disease also known as SLE - are females.

18 Oct 2021

Chilblain-like lesions and COVID-19

The ongoing COVID-19 pandemic brought about by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has also been responsible for various cutaneous manifestations. Among them, chilblain-like lesions (CLL) have been found to occur more frequently.

7 Oct 2021

Higher white matter extracellular free-water related to cognitive dysfunction in lupus patients

Systemic lupus erythematosus (SLE) is an autoimmune disease in which the immune system attacks the body's own tissues, causing widespread inflammation and damage in the affected organs.

18 Sep 2021

NIH begins clinical trial to assess extra COVID-19 vaccine dose in people with autoimmune disease

The National Institutes of Health has begun a clinical trial to assess the antibody response to an extra dose of an authorized or approved COVID-19 vaccine in people with autoimmune disease who did not respond to an original COVID-19 vaccine regimen.

27 Aug 2021

Sphingolipid profile could predict severity of heart disease in African American patients with lupus

A team of researchers at the Medical University of South Carolina report in Frontiers in Immunology that they have identified a type of fat known as a sphingolipid that could predict the severity of heart disease in African American patients with lupus.

16 Aug 2021

Breakthrough SARS-CoV-2 infections in patients with systemic rheumatic diseases

A recent study discusses the clinical characteristics and outcomes of patients with SARDs who were previously vaccinated against SARS-CoV-2.

11 Aug 2021

Defective process in the development of RBCs may trigger lupus

The autoimmune disease lupus may be triggered by a defective process in the development of red blood cells (RBCs), according to a study led by researchers at Weill Cornell Medicine.

11 Aug 2021

New guidance provides valuable direction in the clinical use of HR-pQCT imaging

In recent years, significant progress has been made towards the use of high-resolution peripheral computed tomography (HR-pQCT) imaging in research, and new potential for applications in the clinic have emerged, particularly with the advent of second generation devices.

18 Jun 2021

Immunomodulatory therapies for nephrological autoimmune diseases may help treat severe COVID-19

Various viruses and bacteria have long been known to cause autoimmune diseases where there is such a predisposition. This phenomenon also seems to play a major role in SARS-CoV-2, especially in severe courses.

8 Jun 2021

Effect of COVID-19 pandemic on patients with rheumatoid arthritis, systemic lupus erythematosus

In the Philippines, in the early months of the COVID-19 pandemic, there occurred a supply shortage of hydroxychloroquine and methotrexate. Limited access to medication and the life changes caused from the COVID-19 pandemic may prompt patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) to experience disease flares.

29 May 2021

Facets of SARS-CoV-2 infection and animal models

A new study in the journal Frontiers in Cell and Developmental Biology discusses the ribonucleic acid (RNA) genome of the virus, and the mechanisms by which it establishes infection within the host cell. The researchers also summarize the development of animal models of COVID-19, which will both help understand the clinical features of the illness, and indicate new approaches for the treatment of the infection.

21 May 2021

Lupus Erythematosus News and Research

Research reveals the microbial landscape of patients with systemic lupus erythematosus

Frequency domain optical imaging could reliably identify lupus arthritis and track disease progression

New research focuses on better understanding of lupus in Black women

Chilblain-like lesions and COVID-19

Higher white matter extracellular free-water related to cognitive dysfunction in lupus patients

NIH begins clinical trial to assess extra COVID-19 vaccine dose in people with autoimmune disease

Sphingolipid profile could predict severity of heart disease in African American patients with lupus

Breakthrough SARS-CoV-2 infections in patients with systemic rheumatic diseases

Defective process in the development of RBCs may trigger lupus

New guidance provides valuable direction in the clinical use of HR-pQCT imaging

Immunomodulatory therapies for nephrological autoimmune diseases may help treat severe COVID-19

Effect of COVID-19 pandemic on patients with rheumatoid arthritis, systemic lupus erythematosus

Facets of SARS-CoV-2 infection and animal models

World Malaria Day 2021: An interview with Sir Brian Greenwood

Exposure to silica dust at work may increase risk of autoimmune rheumatic diseases

Researchers identify factors linked to poor outcomes in patients with childhood-onset lupus

Lupus patients with lower vitamin D levels more likely to have metabolic syndrome, insulin resistance

Anti-phospholipid antibodies in severely ill patients not distinctive to COVID-19, says study

Juvenile inflammatory rheumatic disease associated with higher antibody responses to seasonal coronaviruses

Inherited genetic variation may affect the response to cancer immunotherapy

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News